Pralatrexate Is Effective In Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma (PTCL) with Prior Ifosfamide, Carboplatin, and Etoposide (ICE)-Based Regimens

被引：0

作者：

Goy, Andre ^{[1
]}

Pro, Barbara ^{[2
]}

Savage, Kerry Joanne ^{[3
]}

Bartlett, Nancy L. ^{[4
]}

Lechowicz, Mary Jo ^{[5
]}

Jacobsen, Eric D. ^{[6
]}

Young, Faith ^{[7
]}

Crump, Michael ^{[8
]}

Borghaei, Hossein ^{[9
]}

Link, Brian ^{[10
]}

Fruchtman, Steven M. ^{[11
]}

O'Connor, Owen A. ^{[12
]}

机构：

[1] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA

[3] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada

[4] Washington Univ, Sch Med, St Louis, MO USA

[5] Emory Univ Hosp, Atlanta, GA 30322 USA

[6] Dana Farber Canc Inst, Boston, MA 02115 USA

[7] Univ Rochester, Med Ctr, Rochester, NY 14642 USA

[8] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

[9] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA

[10] Univ Iowa, Iowa City, IA USA

[11] Allos Therapeut, Princeton, NJ USA

[12] NYU Langone Med Canter, NYU Canc Inst, Dept Med, New York, NY USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：731 / 732

页数：2